Nanoparticle-based, non-invasive chronic inflammation biomarkers
Treatment of unresolved chronic inflammation that leads to the development of many diseases, including cancer, cardiovascular diseases, autoimmune diseases, neurological diseases and rheumatoid arthritis, has to involve longitudinal image-based characterisation of the process. There is an unmet need for non-invasive diagnostic technology that can be used in conjunction with conventional bio-fluid and biopsy markers. This is particularly important in cases when treatment requires long-term preventative lifestyle changes. The EU-funded Unusual-IV project aims to develop clinical non-invasive, nanoparticle-based biomarkers of inflammation that can help in diagnostics, prediction of the outcome, and the assessment of the response to therapy or preventative strategy.
Fields of science
- medical and health sciencesbasic medicineimmunologyautoimmune diseases
- medical and health sciencesclinical medicinecardiologycardiovascular diseases
- medical and health scienceshealth sciencesinflammatory diseases
- engineering and technologymedical engineeringmedical laboratory technologylaboratory samples analysis
Funding SchemeERC-POC-LS - ERC Proof of Concept Lump Sum Pilot
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.